MedTech Industry Dynamics
MedTech Industry Dynamics
QIAGEN has appointed Jonathan M. Pratt as Chief Executive Officer, who brings more than 25 years of leadership experience across life sciences and laboratory technologies, including serving as CEO of Filtration Group and president of Beckman Coulter Life Sciences.
Mehr lesenDanaher has appointed Julie Sawyer Montgomery as President and Chief Executive Officer, effective October 1, 2026, succeeding Rainer Blair, who will retire and serve as senior advisor until March 2027.
Mehr lesenCanon Medical Systems USA has appointed Tsuneo “Neo” Imai as President and Chief Executive Officer, effective August 1, 2026, succeeding Hisashi Tachizaki in the role.
Mehr lesenHenry Schein has announced leadership transitions including the creation of a new Henry Schein Leadership Team to replace its Executive Management Committee, with three long-serving executives transitioning to Senior Advisor roles effective October 31, 2026.
Mehr lesenSiemens Healthineers has appointed João Seabra as President and Head of the Americas, effective October 1, 2026, succeeding John Kowal, who is departing after years of service including leadership of the Varian business and the Americas region.
Mehr lesenZimmer Biomet has named Chintan Desai as president of its Asia Pacific Region, effective immediately, bringing nearly three decades of MedTech leadership experience from Alcon and GE Healthcare across the region.
Mehr lesenHeartBeam has announced a strategic reorganization to license its 3D ECG signal technology to established partners rather than pursuing direct device sales, while advancing toward heart attack detection as a key platform expansion.
Mehr lesenCleveland Clinic has appointed Dr. Miguel Regueiro as Executive Vice President and Enterprise Chief of Staff, effective June 1, to help shape clinical strategy and lead a global community of more than 6,000 physicians and 4,000 advanced practice providers.
Mehr lesenIntuitive hat Taylor Patton, Global Senior Vice President seines endoluminalen Geschäfts, mit Wirkung zum 1. Juli zum Chief Commercial and Marketing Officer befördert. Er folgt auf Henry Charlton, der zum Senior Vice President of Global Business Operations wird.
Mehr lesenJenaValve hat Edward Sarnowski zum Chief Technology Officer ernannt. Er bringt mehr als 20 Jahre Führungserfahrung in der medizintechnischen Forschung und Entwicklung bei strukturellen Herz- und Transkatheterklappentechnologien mit, um das unternehmenseigene Trilogy Transcatheter Heart Valve System voranzubringen.
Mehr lesen
